Impact of ABO incompatibility and early antibody-mediated rejection on chronic antibody-mediated rejection in kidney transplant patients.
腎移植患者中ABO不相容和早期抗體介導的排斥對慢性抗體介導的排斥的影響。
J Nephrol 2024-01-16
Interleukin-21 promotes Type-1 activation and cytotoxicity of CD56<sup>dim</sup>CD16<sup>bright</sup> natural killer cells during kidney allograft antibody-mediated rejection showing a new link between adaptive and innate humoral allo-immunity.
白介素-21促進腎移植物抗體介導排斥期間CD56<sup>dim</sup>CD16<sup>bright</sup>自然殺傷細胞的1型活化和細胞毒性,顯示適應性和固有體液免疫之間的新聯繫。
Kidney Int 2023-10-03
Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts.
人類腎移植物RNA定序解讀慢性活躍抗體介導排斥的轉錄組特徵。
Kidney Int 2024-02-27
Antibody-mediated rejection diagnosed in early protocol biopsies in high immunological risk kidney transplant recipients.
高免疫風險腎臟移植受者早期協議活檢中診斷的抗體介導排斥反應。
Nephrol Dial Transplant 2024-09-11